The genetic modification of enzymes towards an anti-cancer prodrug activation system
Cancer is the most common cause of death worldwide and therefore attracts significant research attention. Directed enzyme-pro drug therapy offers a selective approach which can kill tumour cells whilst limiting the damage to healthy cells. Nitroreductases have potential applications in enzyme/prodru...
| Main Author: | |
|---|---|
| Published: |
Bangor University
2013
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.664600 |